Fidelity Investments’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $364K | Buy |
10,295
+7,999
| +348% | +$325K | ﹤0.01% | 3246 |
|
|
2025
Q4 | $93.2K | Buy |
2,296
+476
| +26% | +$20.7K | ﹤0.01% | 3787 |
|
|
2025
Q3 | $85.6K | Sell |
1,820
-496
| -21% | -$25.7K | ﹤0.01% | 3728 |
|
|
2025
Q2 | $121K | Buy |
2,316
+1,027
| +80% | +$56.4K | ﹤0.01% | 3526 |
|
|
2025
Q1 | $77.8K | Sell |
1,289
-25,952
| -95% | -$1.67M | ﹤0.01% | 3670 |
|
|
2024
Q4 | $1.86M | Sell |
27,241
-43,748
| -62% | -$3.05M | ﹤0.01% | 2465 |
|
|
2024
Q3 | $5.11M | Sell |
70,989
-10,603
| -13% | -$748K | ﹤0.01% | 2122 |
|
|
2024
Q2 | $5.66M | Buy |
81,592
+80,291
| +6,171% | +$5.86M | ﹤0.01% | 2043 |
|
|
2024
Q1 | $104K | Sell |
1,301
-1,362
| -51% | -$121K | ﹤0.01% | 3267 |
|
|
2023
Q4 | $292K | Buy |
2,663
+37
| +1% | +$3.83K | ﹤0.01% | 2837 |
|
|
2023
Q3 | $265K | Sell |
2,626
-410,399
| -99% | -$47.2M | ﹤0.01% | 2797 |
|
|
2023
Q2 | $56.1M | Buy |
413,025
+410,607
| +16,981% | +$50.1M | ﹤0.01% | 1236 |
|
|
2023
Q1 | $251K | Buy |
2,418
+1,185
| +96% | +$115K | ﹤0.01% | 2901 |
|
|
2022
Q4 | $109K | Buy |
1,233
+274
| +29% | +$22.7K | ﹤0.01% | 3182 |
|
|
2022
Q3 | $77K | Buy |
959
+225
| +31% | +$21.2K | ﹤0.01% | 3340 |
|
|
2022
Q2 | $71K | Sell |
734
-171
| -19% | -$20.5K | ﹤0.01% | 3439 |
|
|
2022
Q1 | $135K | Buy |
905
+465
| +106% | +$64.9K | ﹤0.01% | 3355 |
|
|
2021
Q4 | $63K | Buy |
440
+15
| +4% | +$2.13K | ﹤0.01% | 3181 |
|
|
2021
Q3 | $56K | Buy |
425
+83
| +24% | +$10.9K | ﹤0.01% | 3191 |
|
|
2021
Q2 | $47K | Sell |
342
-24
| -7% | -$3.29K | ﹤0.01% | 3178 |
|
|
2021
Q1 | $48K | Buy |
366
+24
| +7% | +$2.89K | ﹤0.01% | 3055 |
|
|
2020
Q4 | $39K | Buy |
342
+80
| +31% | +$7.58K | ﹤0.01% | 3043 |
|
|
2020
Q3 | $21K | Buy |
262
+28
| +12% | +$2.28K | ﹤0.01% | 3041 |
|
|
2020
Q2 | $17K | Sell |
234
-280
| -54% | -$19.5K | ﹤0.01% | 3018 |
|
|
2020
Q1 | $29K | Sell |
514
-480,164
| -100% | -$44.3M | ﹤0.01% | 2871 |
|
|
2019
Q4 | $53.8M | Sell |
480,678
-16,580
| -3% | -$1.77M | 0.01% | 1178 |
|
|
2019
Q3 | $47.8M | Buy |
497,258
+199,869
| +67% | +$18.8M | 0.01% | 1178 |
|
|
2019
Q2 | $25.4M | Buy |
297,389
+3,480
| +1% | +$286K | ﹤0.01% | 1520 |
|
|
2019
Q1 | $24.4M | Buy |
293,909
+2,373
| +0.8% | +$172K | ﹤0.01% | 1509 |
|
|
2018
Q4 | $18.7M | Buy |
291,536
+2,458
| +0.9% | +$168K | ﹤0.01% | 1575 |
|
|
2018
Q3 | $22.9M | Buy |
289,078
+2,298
| +0.8% | +$178K | ﹤0.01% | 1622 |
|
|
2018
Q2 | $21M | Buy |
+286,780
| New | +$19.5M | ﹤0.01% | 1704 |
|
|
2016
Q3 | – | Sell |
-280,000
| Closed | -$13.4M | – | 2659 |
|
|
2016
Q2 | $13.4M | Sell |
280,000
-758,072
| -73% | -$32.1M | ﹤0.01% | 1838 |
|
|
2016
Q1 | $43.5M | Sell |
1,038,072
-1,895,776
| -65% | -$74.4M | 0.01% | 1300 |
|
|
2015
Q4 | $129M | Sell |
2,933,848
-398,232
| -12% | -$17.3M | 0.02% | 859 |
|
|
2015
Q3 | $159M | Buy |
3,332,080
+577,543
| +21% | +$31.7M | 0.02% | 745 |
|
|
2015
Q2 | $161M | Buy |
2,754,537
+567,498
| +26% | +$30.6M | 0.02% | 809 |
|
|
2015
Q1 | $110M | Buy |
2,187,039
+228,792
| +12% | +$11.2M | 0.01% | 984 |
|
|
2014
Q4 | $88M | Sell |
1,958,247
-19,519
| -1% | -$818K | 0.01% | 1063 |
|
|
2014
Q3 | $72.9M | Buy |
1,977,766
+75,419
| +4% | +$2.99M | 0.01% | 1122 |
|
|
2014
Q2 | $84M | Sell |
1,902,347
-389,997
| -17% | -$17.7M | 0.01% | 1102 |
|
|
2014
Q1 | $99.6M | Buy |
2,292,344
+427,744
| +23% | +$19.1M | 0.01% | 990 |
|
|
2013
Q4 | $79.2M | Buy |
1,864,600
+197,000
| +12% | +$7.49M | 0.01% | 1088 |
|
|
2013
Q3 | $56.7M | Buy |
1,667,600
+54,600
| +3% | +$1.78M | 0.01% | 1213 |
|
|
2013
Q2 | $50.4M | Buy |
+1,613,000
| New | +$52.3M | 0.01% | 1242 |
|
Other funds holding CNMD
VPM
VCM
CB
Fidelity Investments's CNMD Position: Q1 2026 in Review
Fidelity Investments increased its CONMED (CNMD) stake by 348% in Q1 2026, buying an estimated $325K and bringing the position to 10,295 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #3246.
Fidelity Investments first reported a position in CNMD in Q2 2013 and has held it in 45 quarters since. The position peaked at $161M in Q2 2015. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Fidelity Investments held 10,295 shares of CONMED worth $364K as of Q1 2026.
- Fidelity Investments bought 7,999 CONMED shares in Q1 2026, an estimated $325K.
- CONMED made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3246 holding.
- Fidelity Investments first reported a position in CONMED in Q2 2013 and has held it in 45 quarters since.
- Fidelity Investments's CONMED position peaked at $161M in Q2 2015.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.